CIRM team shines at ASGCT annual meeting in sunny Los Angeles

The California Institute for Regenerative Medicine (CIRM) team spent a week in sunny Los Angeles spreading awareness of its mission at the American Society of Gene & Cell Therapy (ASGCT) annual meeting

The goal of the meeting is to provide a place for people in the cell and gene therapy field to learn from the latest scientific research, stay up to date on new technologies and make career-advancing connections with peers. CIRM was a gold sponsor of the event. 

In addition to setting up a booth in the exhibit hall, CIRM participated in two sessions including a workshop that highlights the work being done in cell and gene therapy to advance neurological disorders. Speakers highlighted the impact of CIRM funding on research and the use of technologies such as digital biomarkers, optogenetics, and imaging to advance understanding of such disorders. 

Abla A. Creasey, Shyam Patel, Hartmuth Kolb, Krystof Bankiewicz, Claire Henchcliffe, Peter Francis, Russ Lebovitz

CIRM also participated in a workshop to recognize the work being done through the Accelerating Medicines Partnership Program Bespoke Gene Therapy Consortium (BGTC).  

The BGTC is a public-private partnership, managed by Foundation for the National Institutes of Health (FNIH), that brings together the National Institutes of Health (NIH), the U.S. Food and Drug Administration (FDA), and multiple public and private sector organizations like CIRM to streamline the development and delivery of gene therapies for rare diseases. 

The workshop at ASGCT was the BGTC’s first annual meeting, and highlighted progress so far, engaged with the community on next steps, and provided member and patient perspectives on overcoming the challenges faced in the gene therapy field. Read more about CIRM’s involvement in the BGTC here

Lisa Kadyk, Wenlin Zhang (UCLA), Abla A. Creasey, Ross Okamura, Anthony Aldave (UCLA), MM, Doug Chung (UCLA)

Throughout the week-long conference, CIRM had many great conversations with presenters, grantees, researchers and partnering organizations about its funding opportunities, programs and mission.  

Sponsoring and attending conferences like ASGCT not only supports the advancement of cell and gene therapies in California but also provides opportunities for the public to share ideas and feedback directly with CIRM that help shape the future of its programs.  

Check out more photos from the event:

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.